14-day Premium Trial Subscription Try For FreeTry Free
$0.0135
+0 (+0%)
At Close: Apr 05, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0135 $0.0135 Friday, 5th Apr 2024 ATHX stock ended at $0.0135. During the day the stock fluctuated 0% from a day low at $0.0135 to a day high of $0.0135.
90 days $0.0116 $0.0212
52 weeks $0.0116 $1.14

Historical Athersys prices

Date Open High Low Close Volume
Nov 09, 2023 $0.0275 $0.0320 $0.0224 $0.0260 636 958
Nov 08, 2023 $0.0280 $0.0329 $0.0211 $0.0275 1 229 993
Nov 07, 2023 $0.0300 $0.0336 $0.0265 $0.0280 1 260 361
Nov 06, 2023 $0.0345 $0.0370 $0.0268 $0.0310 1 433 036
Nov 03, 2023 $0.0371 $0.0377 $0.0300 $0.0325 877 931
Nov 02, 2023 $0.0320 $0.0405 $0.0300 $0.0365 673 228
Nov 01, 2023 $0.0370 $0.0426 $0.0297 $0.0334 2 153 230
Oct 31, 2023 $0.0300 $0.0349 $0.0251 $0.0349 2 413 589
Oct 30, 2023 $0.0311 $0.0450 $0.0285 $0.0345 4 606 829
Oct 27, 2023 $0.0225 $0.0318 $0.0192 $0.0318 5 229 662
Oct 26, 2023 $0.0204 $0.0225 $0.0190 $0.0200 1 542 815
Oct 25, 2023 $0.0200 $0.0245 $0.0170 $0.0192 1 647 580
Oct 24, 2023 $0.0165 $0.0276 $0.0165 $0.0195 1 090 400
Oct 23, 2023 $0.0247 $0.0255 $0.0160 $0.0173 2 480 972
Oct 20, 2023 $0.135 $0.135 $0.0220 $0.0240 3 109 065
Oct 19, 2023 $0.0277 $0.0277 $0.0277 $0.0277 0
Oct 18, 2023 $0.135 $0.135 $0.0230 $0.0277 17 903 625
Oct 17, 2023 $0.135 $0.135 $0.0982 $0.102 78 391 562
Oct 16, 2023 $0.106 $0.110 $0.0938 $0.0981 6 849 540
Oct 13, 2023 $0.110 $0.130 $0.102 $0.103 10 629 772
Oct 12, 2023 $0.127 $0.144 $0.113 $0.119 10 235 324
Oct 11, 2023 $0.148 $0.165 $0.120 $0.140 57 907 769
Oct 10, 2023 $0.126 $0.180 $0.105 $0.120 19 954 341
Oct 09, 2023 $0.310 $0.325 $0.275 $0.300 621 255
Oct 06, 2023 $0.360 $0.380 $0.293 $0.302 1 301 705
Click to get the best stock tips daily for free!

About Athersys

Athersys Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study f... ATHX Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT